SUCCESSFUL GENERATION OF TUMOR-INFILTRATING LYMPHOCYTE (TIL) PRODUCT FROM RENAL CELL CARCINOMA (RCC) TUMORS FOR ADOPTIVE CELL THERAPY

被引：1
|
作者：
Halbert, Brian
Einstein, David
McDermott, David
Andrianopoulos, Emanuelle
Gupta, Mamta
Seery, Virginia
Onimus, Kenneth
Herman, Courtney
Wells, Adrian
Lakshmipathi, Shwetha
Natarajan, Arvind
Veerapathran, Anand
Bhatt, Rupal
Halbert, Brian
机构：
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷
关键词：
D O I：
10.1136/jitc-2021-SITC2021.176
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
176
引用
收藏
页码：A188 / A188
页数：1
相关论文
共 50 条
  • [41] Tumor Infiltrating Lymphocyte Therapy for Metastatic Melanoma: Analysis of Tumors Resected for TIL
    Goff, Stephanie L.
    Smith, Franz O.
    Klapper, Jacob A.
    Sherry, Richard
    Wunderlich, John R.
    Steinberg, Seth M.
    White, Donald
    Rosenberg, Steven A.
    Dudley, Mark E.
    Yang, James C.
    JOURNAL OF IMMUNOTHERAPY, 2010, 33 (08) : 840 - 847
  • [42] A novel approach for generating tumor infiltrating lymphocytes (TIL) from renal cell carcinoma (RCC) in the presence of autologous Dendritic cells (DC) a tumor antigen.
    Schiltz, PM
    Nayak, SK
    Dillman, RO
    JOURNAL OF LEUKOCYTE BIOLOGY, 1998, : 87 - 87
  • [43] Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma
    Mullinax, John E.
    Hall, MacLean
    Prabhakaran, Sangeetha
    Weber, Jeffrey
    Khushalani, Nikhil
    Eroglu, Zeynep
    Brohl, Andrew S.
    Markowitz, Joseph
    Royster, Erica
    Richards, Allison
    Stark, Valerie
    Zager, Jonathan S.
    Kelley, Linda
    Cox, Cheryl
    Sondak, Vernon K.
    Mule, James J.
    Pilon-Thomas, Shari
    Sarnaik, Amod A.
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [44] Tumor-infiltrating lymphocytes for adoptive cell therapy: recent advances, challenges, and future directions
    Granhoj, Joachim Stoltenborg
    Jensen, Agnete Witness Praest
    Presti, Mario
    Met, Ozcan
    Svane, Inge Marie
    Donia, Marco
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (05) : 627 - 641
  • [45] Trial in Progress: Phase 1/2 Study of OBX-115 Engineered Tumor-Infiltrating Lymphocyte (TIL) Cell Therapy in Patients with Advanced Solid Tumors
    Schoenfeld, A. J.
    Warner, A. Betof
    Chesney, J. A.
    Thomas, S. S.
    Moyers, J. T.
    In, G. K.
    Shoushtari, A. N.
    Samhouri, Y.
    Hari, P.
    Ramsingh, G.
    Renard, C.
    Prabhakar, P.
    Mclaughlin, L.
    He, K.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S390 - S390
  • [46] Minimally cultured tumor-infiltrating lymphocytes display optimal characteristics for adoptive cell therapy
    Tran, Khoi Q.
    Zhou, Juhua
    Durflinger, Katherine H.
    Langhan, Michelle M.
    Shelton, Thomas E.
    Wunderlich, John R.
    Robbins, Paul F.
    Rosenberg, Steven A.
    Dudley, Mark E.
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (08) : 742 - 751
  • [47] Guillain-Barre syndrome after adoptive cell therapy with tumor-infiltrating lymphocytes
    Orcurto, Angela
    Hottinger, Andreas
    Wolf, Benita
    Navarro Rodrigo, Blanca
    Ochoa de Olza, Maria
    Auger, Aymeric
    Kuntzer, Thierry
    Comte, Denis
    Zimmer, Virginie
    Gannon, Philippe
    Kandalaft, Lana
    Michielin, Olivier
    Zimmermann, Stefan
    Harari, Alexandre
    Trueb, Lionel
    Coukos, George
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [48] A Preclinical Model To Study Tumor. Infiltrating Lymphocyte (TIL) Anergy/Exhaustion in Adoptive T Cell Therapy (ACT) of Thoracic Malignancies
    Moon, Edmund K.
    Liang, Wang C.
    Caleph, Wilson
    Carpenito, Carmine
    Douglas, Dolfi
    James, Riley R.
    Wherry, John E.
    Carl, June H.
    Albelda, Steven M.
    MOLECULAR THERAPY, 2012, 20 : S95 - S95
  • [49] Limited usage of the V beta T-cell receptor (TCR) in tumor infiltrating lymphocytes (TIL) of renal cell carcinoma (RCC) in vivo.
    Barth, C
    Krause, K
    Stachowski, J
    Vorreuther, R
    Engelmann, U
    Baldamus, C
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A2227 - A2227
  • [50] VARIABLE EXPRESSION OF CD3-ZETA CHAIN IN TUMOR-INFILTRATING LYMPHOCYTES (TIL) DERIVED FROM RENAL-CELL CARCINOMA - RELATIONSHIP WITH TIL PHENOTYPE AND FUNCTION
    TARTOUR, E
    LATOUR, S
    MATHIOT, C
    THIOUNN, N
    MOSSERI, V
    JOYEUX, I
    DENGHIEN, CD
    LEE, RS
    DEBRE, B
    FRIDMAN, WH
    INTERNATIONAL JOURNAL OF CANCER, 1995, 63 (02) : 205 - 212
12345